Zhejiang Benli Technology Co., Ltd. (SZSE: 301065)
Health Care · Pharmaceuticals · CN
CN¥19.18
-0.57% today · -20.5% 1Y
Zhejiang Benli Technology Co., Ltd. (SZSE: 301065) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $294.37M.
Over the last twelve months the share price has lost 20.5%, trading between 16.60 and 25.17.
Tweenvest scores Zhejiang Benli Technology Co., Ltd. across four factors: quality 68/100, value 58/100, growth 47/100, dividend 40/100. Its strongest factor is quality.
301065 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $294.37M
- Revenue (TTM)
- $92.57M
- P/E
- 27.10
- EPS
- 0.71
- Dividend yield
- 1.56%
- Beta (5Y)
- 0.24
- 52-week high
- CN¥25.17
- 52-week low
- CN¥16.60
- Avg volume (3M)
- —
- Shares outstanding
- 103.17M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,239.69 | -1.25% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.54 | +0.48% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $149.86 | -1.76% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.88 | -0.68% |
Figures last refreshed Aug 18, 2026.